Pancreatic cancer study: understanding tumor anatomy
Part of Cancer clinical trials.
This study is looking at the anatomy and clinical features of pancreatic adenocarcinoma. If you have a pancreatic mass that has been examined by ultrasound, CT scan, or biopsy, you may be able to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a pancreatic mass that has been checked by an ultrasound with a fine needle biopsy
- Or you have a pancreatic mass that has been examined by a CT scan with contrast dye and/or a biopsy of the mass or other spots
- Or you have been diagnosed with pancreatic adenocarcinoma by a tissue sample (biopsy or cytology)
- You do not have another type of pancreatic tumor (not adenocarcinoma)
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at a patient’s “metabolic profile” (how the body’s chemicals are used) in people with certain liver and pancreatic tumors. It may help doctors better understand these cancers and improve how they are evaluated for treatment.
This study looks for new markers in the blood or tissue of people with a pancreatic mass that might be cancer. It uses samples from a routine biopsy or surgery to help doctors learn more about the disease.
This study collects medical and lab information from adults with pancreatic cancer to help researchers understand care and outcomes. You may be asked for follow-up visits and basic data, and it may be used to improve future treatments.
This study looks at specific body chemistry pathways in pancreatic cancer tissue to better understand what may help treatment work. If you are having pancreatic surgery, the researchers will take extra small tissue samples during the operation to study tumor and normal tissue.
This trial studies and analyzes tissue samples from people who had surgery for exocrine pancreatic (pancreatic duct-type) cancer. It may help researchers better understand the disease biology and improve future care.
This study follows how pancreatic cancer changes over time while you’re receiving treatment before surgery. It may help doctors understand how the cancer evolves and guide better future treatment choices.
Hear when a new Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.